Several Options for Frontline Treatment of MCL
In this MEDtalk from EHA 2025, Professor Mats Jerkeman, MD, PhD, from Lund University and Skåne University Hospital, highlights several possible frontline treatment strategies in mantle cell lymphoma that incorporate BTK inhibitors. He provides his perspective on frontline treatment strategies for younger MCL patients as well as older and high-risk patients.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in
